Aptamer-Based Diagnostics and Therapeutics

by Sarah Shigdar
Published 2019-01-01

Novel Detection of Nasty Bugs, Prevention Is Better than Cure

by Mia Strom, Tamsyn Crowley, Sarah Shigdar
Published 2021-12-01

Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach

by Chris Vi, Giovanni Mandarano, Sarah Shigdar
Published 2021-06-01

Antibodies, Nanobodies, or Aptamers—Which Is Best for Deciphering the Proteomes of Non-Model Species?

by Poshmaal Dhar, Rasika M. Samarasinghe, Sarah Shigdar
Published 2020-04-01

Aptamers and Glioblastoma: Their Potential Use for Imaging and Therapeutic Applications

by Emma M. Hays, Wei Duan, Sarah Shigdar
Published 2017-11-01

Non-Invasive Delivery of Therapeutics into the Brain: The Potential of Aptamers for Targeted Delivery

by Bakhtiar Bukari, Rasika M. Samarasinghe, Jinjutha Noibanchong, Sarah L. Shigdar
Published 2020-05-01

Radiolabelled Aptamers for Theranostic Treatment of Cancer

by Umair Khalid, Chris Vi, Justin Henri, Joanna Macdonald, Peter Eu, Giovanni Mandarano, Sarah Shigdar
Published 2018-12-01

Epithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cells

by Li L, Xiang DX, Shigdar S, Yang WR, Li Q, Lin J, Liu KX, Duan W
Published 2014-02-01

Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures

by Kamal Rahimizadeh, Hadi AlShamaileh, Milena Fratini, Madhuri Chakravarthy, Michelle Stephen, Sarah Shigdar, Rakesh N. Veedu
Published 2017-11-01

EpCAM Immunotherapy versus Specific Targeted Delivery of Drugs

by Joanna Macdonald, Justin Henri, Kislay Roy, Emma Hays, Michelle Bauer, Rakesh Naduvile Veedu, Normand Pouliot, Sarah Shigdar
Published 2018-01-01

The use of sensitive chemical antibodies for diagnosis: detection of low levels of EpCAM in breast cancer.

by Sarah Shigdar, Christine Qian, Li Lv, Chunwen Pu, Yong Li, Lianhong Li, Manju Marappan, Jia Lin, Lifen Wang, Wei Duan
Published 2013-01-01

Enhanced antitumor efficacy and reduced systemic toxicity of sulfatide-containing nanoliposomal doxorubicin in a xenograft model of colorectal cancer.

by Jia Lin, Yan Yu, Sarah Shigdar, Ding Zhi Fang, Jun Rong Du, Ming Q Wei, Andrew Danks, Ke Liu, Wei Duan
Published 2012-01-01

Improved efficacy and reduced toxicity of doxorubicin encapsulated in sulfatide-containing nanoliposome in a glioma model.

by Jia Lin, Sarah Shigdar, Ding Zhi Fang, Dognxi Xiang, Ming Q Wei, Andrew Danks, Lingxue Kong, Lianghong Li, Liang Qiao, Wei Duan
Published 2014-01-01

Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo [Corrigendum]

by Xiang DX, Zheng Y, Duan W, Li XJ, Yin JJ, Shigdar S, O'Connor ML, Marappan M, Zhao XJ, Miao YQ, Xiang B, Zheng CL
Published 2013-12-01

Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo

by Xiang DX, Zheng Y, Duan W, Li XJ, Yin JJ, Shigdar S, O'Connor ML, Marappan M, Zhao XJ, Miao YQ, Xiang B, Zheng CL
Published 2013-10-01

Aptamers as Theranostic Agents: Modifications, Serum Stability and Functionalisation

by Wei Duan, Lingxue Kong, Santanu Bhattacharya, ChunGuang Li, Yimin Zhu, Shu-Feng Zhou, Ming Wei, Liang Qiao, Hadi Al.Shamaileh, Sarah Shigdar, Joanna Macdonald, Michael O'Connor, Tao Wang, Dongxi Xiang
Published 2013-10-01

Author Correction: Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells

by Hadi AlShamaileh, Tao Wang, Dongxi Xiang, Wang Yin, Phuong Ha-Lien Tran, Roberto A. Barrero, Pei-Zhuo Zhang, Yong Li, Lingxue Kong, Ke Liu, Shu-Feng Zhou, Yingchun Hou, Sarah Shigdar, Wei Duan
Published 2020-12-01

Aptamer-mediated survivin RNAi enables 5-fluorouracil to eliminate colorectal cancer stem cells

by Hadi AlShamaileh, Tao Wang, Dongxi Xiang, Wang Yin, Phuong Ha-Lien Tran, Roberto A. Barrero, Pei-Zhuo Zhang, Yong Li, Lingxue Kong, Ke Liu, Shu-Feng Zhou, Yingchun Hou, Sarah Shigdar, Wei Duan
Published 2017-07-01